Arteriogenesis	O
:	O
the	O
development	O
and	O
growth	O
of	O
collateral	B-Multi-tissue_structure
arteries	I-Multi-tissue_structure
.	O

In	O
patients	O
with	O
atherosclerotic	O
vascular	B-Multi-tissue_structure
diseases	O
,	O
collateral	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
bypassing	O
major	O
arterial	B-Pathological_formation
obstructions	I-Pathological_formation
have	O
frequently	O
been	O
observed	O
.	O

This	O
may	O
explain	O
why	O
some	O
patients	O
remain	O
without	O
symptoms	O
or	O
signs	O
of	O
ischemia	O
.	O

The	O
term	O
"	O
arteriogenesis	O
"	O
was	O
introduced	O
to	O
differentiate	O
the	O
formation	O
of	O
collateral	B-Multi-tissue_structure
arteries	I-Multi-tissue_structure
from	O
angiogenesis	O
,	O
which	O
mainly	O
occurs	O
in	O
the	O
ischemic	O
,	O
collateral	O
flow	O
-	O
dependent	O
tissue	B-Tissue
.	O

Many	O
observations	O
in	O
various	O
animal	O
models	O
and	O
humans	O
support	O
that	O
the	O
remodeling	O
of	O
preexisting	O
collateral	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
is	O
the	O
mechanism	O
of	O
collateral	B-Multi-tissue_structure
artery	I-Multi-tissue_structure
formation	O
.	O

This	O
remodeling	O
process	O
seems	O
to	O
be	O
mainly	O
flow	O
-	O
mediated	O
.	O

It	O
involves	O
endothelial	B-Cell
cell	I-Cell
activation	O
,	O
basal	B-Cellular_component
membrane	I-Cellular_component
degradation	O
,	O
leukocyte	B-Cell
invasion	O
,	O
proliferation	O
of	O
vascular	B-Cell
cells	I-Cell
,	O
neointima	B-Tissue
formation	O
(	O
in	O
most	O
species	O
studied	O
)	O
,	O
and	O
changes	O
of	O
the	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
.	O

The	O
contribution	O
of	O
ischemia	O
to	O
arteriogenesis	O
is	O
still	O
unclear	O
,	O
but	O
arteriogenesis	O
clearly	O
can	O
occur	O
in	O
the	O
absence	O
of	O
any	O
significant	O
ischemia	O
.	O

It	O
is	O
questionable	O
,	O
whether	O
collateral	B-Multi-tissue_structure
arteries	I-Multi-tissue_structure
also	O
form	O
de	O
novo	O
in	O
ischemic	O
vascular	B-Multi-tissue_structure
diseases	O
.	O

A	O
better	O
understanding	O
of	O
the	O
mechanisms	O
of	O
arteriogenesis	O
will	O
be	O
important	O
for	O
the	O
design	O
of	O
more	O
effective	O
strategies	O
for	O
the	O
treatment	O
of	O
patients	O
with	O
ischemic	O
vascular	B-Multi-tissue_structure
diseases	O
.	O

